Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
39 results about "1,4-Benzoquinone" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
1,4-Benzoquinone, commonly known as para-quinone, is a chemical compound with the formula C₆H₄O₂. In a pure state, it forms bright-yellow crystals with a characteristic irritating odor, resembling that of chlorine, bleach, and hot plastic or formaldehyde. This six-membered ring compound is the oxidized derivative of 1,4-hydroquinone. The molecule is multifunctional: it exhibits properties of a ketone, forming an oxime; an oxidant, forming the dihydroxy derivative; and an alkene, undergoing addition reactions, especially those typical for α,β-unsaturated ketones. 1,4-Benzoquinone is sensitive toward both strong mineral acids and alkali, which cause condensation and decomposition of the compound.
Nutraceutical composition and method of use for treatment / prevention of cancer
InactiveUS20070248693A1Function increaseAbility to createBiocideAlgae medical ingredients1,4-BenzoquinonePantothenic acid
The invention describes a pharmaceutical composition and method for treating cancer comprised of A) 2,3-dimethoxy-5-methyl-1,4-benzoquinone and / or B) at least one of wild yam root, teasel root, balm of gilead bud, bakuchi seed, dichroa root, kochia seed, kanta kari, bushy knotweed rhizome, arjun, babul chall bark, opopanax and bhumy amalaki; optionally one or more of frankincense, garcinia fruit, vitex, dragons blood, mace, sage and red sandalwood with at least c) one compound capable of maximizing oxidative mitochondrial function preferably riboflavin or vitamin B2 derivatives, FAD, FMN, 5-amino-6-(5′-phosphoribitylamino)uracil, 6,7-Dimethyl-8-(1-D-ribityl)lumazine, ribitol, 5,6-dimethylbenzimidazole, tetrahydrobiopterin, vitamin B1, lipoic acid, biotin, vitamin B6, vitamin B12, folate, niacin, vitamin C and pantothenate and / or d) at least one lactic acid dehydrogenase inhibitor (preferably 2′,3,4′5,7-pentahydroxyflavone) and optionally f) an alkalizing agent (aloe vera, chlorella, wheat grass, sodium or potassium bicarbonate, potassium) g) an antiproliferative herb (speranskia or goldenseal) and h) a pharmaceutically acceptable carrier.
Owner:MAZZIO ELIZABETH +1
Nutraceutical composition and method of use for treatment / prevention of cancer
ActiveUS20100209388A1Easy to understandReduce weightOrganic active ingredientsBiocideMyrrh1,4-Benzoquinone
The invention describes a nutraceutical composition and method for preventing / treating cancer comprised of A) quinones (2,3-dimethoxy-5-methyl-1,4-benzoquinone, thymoquinone, tocopherolquinone) B) compounds capable of maximizing oxidative mitochondrial function preferably riboflavin, FAD, FMN, 6,7-Dimethyl-8-(1-D-ribityl)lumazine, ribitol, 5,6-dimethylbenzimidazole, tetrahydrobiopterin, vitamin B1, lipoic acid, biotin, vitamin B6, vitamin B12, folate, B3, C and pantothenate C) lactic acid dehydrogenase inhibitors; 2′,3,4′5,7-pentahydroxyflavone, epigallocatechin gallate, quercetin, citric acid, rosemary, black walnut, clove, nutmeg, licorice root, coriander, cinnamon, ginger root, myrrh gum and green tea D) alkalizing agents: aloe vera, chlorella, wheat grass, apple cider vinegar, burdock root, kudzu root, alfalfa, barley grass, spirulina, parsley leaf, calcium, magnesium, potassium or bicarbonate salts E) potent tumoricidal herbs; gromwell root, wild yam, beth root, teasel root, balm of gilead bud, frankincense, bakuchi seed, dichroa root, kochia seed, kanta kari, sweet myrrh, galbanum, garcinia fruit, mace, white sage and tumoricial plant derived constituents: gambogic acid, shikonin, diosmin or boswellic acid F) an antiproliferative herb (speranskia or goldenseal) and G) a pharmaceutically acceptable carrier.
Owner:FLORIDA A&M UNIVERSITY
Novel red BODIPY fluorescent dye and preparation method and application thereof
InactiveCN102702768ANarrow absorbencyNarrow fluorescence emission spectrumMethine/polymethine dyesMicrobiological testing/measurementChemical reaction1,4-Benzoquinone
The invention relates to a novel red BODIPY fluorescent dye with the chemical formula of C10+mH7+nBF2N2+xOy, wherein m, n, x and y are integers from 0 to 100. The preparation method comprises the following steps: dissolving pyrrole with substituent groups R1, R2 and R3 in an organic solution; adding ethyl glyoxylate together with nitrogen to the organic solution for a chemical reaction by using trifluoroacetic acid or toluenesulfonic acid as a catalyst; adding 2,3-dichloro-5,6-dicyano-1,4-benzoquinone oxidative dehydrogenation; and adding organic amine and a boron trifluoride diethyl ether solution for another reaction. After the reaction solution is concentrated, chromatography is performed with a silicagel column to obtain the fluorescent dye. The fluorescent dye can be used for cell imaging, fluorescent probe or laser dye. The fluorescent dye has the advantages that the ultraviolet-visible absorption spectrum and the fluorescence emission spectrum of the fluorescent dye are narrow; fluorescent quanta has high efficiency and good light stability; and the fluorescent dye has simple molecular structure and can be synthesized easily, so as to facilitate popularization and application.
Owner:TIANJIN UNIVERSITY OF TECHNOLOGY
Novel BODIPY flourescent dye with adjustable emission wavelength and preparation method thereof
InactiveCN103194085ASimple molecular structureThe synthesis method is simpleMethine/polymethine dyesBiological testingFluorescence1,4-Benzoquinone
The invention relates to a novel BODIPY flourescent dye with an adjustable emission wavelength. The chemical formula of the novel BODIPY flourescent dye is C15+mH6+nBF7N2+xOy, wherein m, n, x and y are integers from 0 to 100. The preparation method comprises the following steps of: dissolving pentafluorobenzaldehyde into an organic solvent, adding pyrrole with substituent groups R1, R2, R3 in the presence of nitrogen, and reacting by taking trifluoroacetic acid or para-toluenesulfonic acid as a catalyst; then adding 2,3-dichloro-5,6-dicyano-1,4-benzoquinone for oxidative dehydrogenation; and finally adding organic amine and boron trifluoride diethyl etherate solutions for continuous reaction, and concentrating a reaction liquid to obtain a target object by utilizing silica gel column chromatography. The novel BODIPY flourescent dye disclosed by the invention can be used for cell imaging and the like, can be adjusted in emission wavelength from a visible region to a near-infrared region and has the advantages of narrow fluorescence emission spectrum, high fluorescence quantum efficiency, good light stability, simple molecular structure, easiness and convenience for synthetic method and easiness for popularization and application.
Owner:TIANJIN UNIVERSITY OF TECHNOLOGY
Novel Intermediates, Process for Their Preparation and Process for the Preparation of Coq10 Employing the Said Novel Intermediates
InactiveUS20080200702A1Speed up the processSimple and cost-effective and commercially applicableOrganic compound preparationQuinone preparation by oxidation1,4-BenzoquinoneMethyl group
The present invention relates to an improved process for the preparation of Coenzyme Q. Coenzyme Q10 or CoQ10 has the chemical name 2-[(all-trans)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl-1,4-benzoquinone and has the formula I.The invention also provides new intermediates useful for the preparation of CoQ10 and processes for their preparation.
Owner:NICHOLAS PIRAMAL INDIA LTD
Positive electrode active material for nonaqueous secondary battery
InactiveUS20120196182A1Sufficient charge/discharge capacityExcellent cycle characteristicsOrganic chemistrySecondary cellsBenzoquinone CompoundSimple Organic Compounds
The present invention provides a positive electrode active material for nonaqueous solvent secondary batteries, comprising, as an active ingredient, a 1,4-benzoquinone compound having lower alkoxy groups as substitutes, and a nonaqueous secondary battery comprising the positive electrode active material as a constituent. According to the invention, a nonaqueous secondary battery having a high energy density and excellent cycle characteristics can be obtained by using a positive electrode active material composed of an organic compound with a low environmental load.
Owner:NAT INST OF ADVANCED IND SCI & TECH
Non-aqueous electrolyte for primary battery, and non-aqueous electrolyte primary battery using the same
InactiveUS20100129723A1Stable jobReduce voltage droopCell electrodesOrganic electrolyte cellsHigh rate1,4-Benzoquinone
It is an object to provide a non-aqueous electrolyte for use in a primary battery, which is advantageous in that the primary battery using the non-aqueous electrolyte suffers less lowering of voltage during the high-rate discharge and can work stably. Disclosed are a non-aqueous electrolyte for use in a primary battery, comprising at least one organic compound selected from the group consisting of 1,2-benzoquinone, 1,4-naphthoquinone, 1,2-naphthoquinone, 9,10-anthraquinone, 1,4-anthraquinone, acenaphthenequinone, and a derivative of 1,2-benzoquinone, 1,4-naphthoquinone, 1,2-naphthoquinone, 9,10-anthraquinone, 1,4-anthraquinone, acenaphthenequinone, or 1,4-benzoquinone; a non-aqueous electrolyte for use in a primary battery, comprising an organic compound exhibiting a reduction potential of 2.5 V or higher and a quantity of electricity in reduction reaction per electrode area of 1,000 mC / cm2 or lower under specific conditions; and a non-aqueous electrolyte for use in a primary battery, having a reduction potential of 2.5 V or higher and a quantity of electricity in reduction reaction per electrode area of 1,000 mC / cm2 or lower.
Owner:MITSUBISHI CHEM CORP
Positive electrode active material for nonaqueous secondary battery
InactiveCN102598374AReduce environmental loadExcellent environmental loadCell electrodesSecondary cellsHigh energyAlkoxy group
Owner:NAT INST OF ADVANCED IND SCI & TECH
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
Disclosed herein are compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging, or for modulating one or more energy biomarkers, normalizing one or more energy biomarkers, or enhancing one or more energy biomarkers, wherein the compounds are tocopherol quinone derivatives. Further disclosed are compounds, compositions, and methods for treatment of, or prophylaxis against, radiation exposure.
Owner:PTC THERAPEUTICS INC
Synthesis method of 2,5-bis(substituted amino)-1,4-benzoquinone compound
InactiveCN102199100ACover costsMake up yieldOrganic chemistryOrganic compound preparationState of artWater baths
The invention discloses a synthesis method of a 2,5-bis(substituted amino)-1,4-benzoquinone compound. The method comprises the following steps of: dissolving hydroquinone in a polar solvent, diluting aliphatic or aromatic primary amine and secondary amines with a polar solvent, dripping diluted aliphatic or aromatic primary amine and secondary amines to a hydroquinone solution to obtain a mixed solution, heating the mixed solution in a water bath and finally separating reaction liquid to obtain a product. The synthesis method provided by the invention, with inexpensive hydroquinone, aliphatic or aromatic primary amine and secondary amines as raw materials, overcomes the defect that the synthesis method in the prior art has high production cost or low yield, embodies green, energy-saving and environmental protection concepts, and has high potential application value.
Owner:HUAIHAI INST OF TECH
Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone
Owner:SANTHERA PHARMA SCHWEIZ
Preparation method of permanent violet pigment
The invention discloses a preparation method of a permanent violet pigment. The method comprises the following steps: dissolving 3-amino-N-ethyl carbazole in an organic solvent and carrying out a condensation reaction by adding chloranil in the presence of an acid-binding agent so as to obtain an organic solution containing 2,5-dichloro-3,6-di(9-ethyl-3-carbazole amino)-1,4-benzoquinone after the reaction; adding a metal salt catalyst into the organic solution obtained in the step a or simultaneously adding the metal salt catalyst and a quinone compound cocatalyst into the organic solution; feeding air or oxygen into a reaction kettle to reach a certain pressure; carrying out heat preservation at 120-180 DEG C for 2-10 hours; cooling to 80-120 DEG C after the reaction; washing a filter cake obtained after filtering with a small amount of organic solvent; then, respectively washing with methyl alcohol and water and drying, thereby obtaining a crude permanent violet pigment product. According to the method, a traditional poisonous and harmful closed-loop agent is not adopted, so that the cost of raw materials is saved; the generation of byproducts is reduced, so that the selectivity and total yield of the reaction are improved. Thus, less environmental pollution is generated.
Owner:NANTONG HAIDI CHEM
Transmucosal administration system for a pharmaceutical drug
ActiveUS20130189343A1Inhibit metabolismHigh plasma levelBiocideSenses disorder1,4-BenzoquinonePharmaceutical drug
Owner:SANTHERA PHARMA (SWITZERLAND) LTD
Novel compounds for treating mitochondrial disease
ActiveUS20180305328A1High expressionReduce fragmentationSenses disorderNervous disorderDiseaseMedicine
The invention relates to novel compounds that are useful for modulating cellular ROS. The compounds are amide-derivatives of 2-hydroxy-2-methyl-4-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-butanoic acid. The compounds of the invention are formulated into pharmaceutical or cosmetic compositions. The invention further relates to methods wherein the compounds of the invention are used for treating or preventing diseases associated with increased ROS levels mitochondrial disorders and / or conditions associated with mitochondrial dysfunction, including adverse drug effects. The invention also relates to cosmetic methods for treating or delaying further aging of the skin and veterinary applications.
Owner:KHONDRION IP
Process for conversion of phenol to hydroquinone and quinones
InactiveUS6872857B1Avoid disadvantagesInhibition formationOrganic compound preparationQuinone preparation by oxidation1,4-BenzoquinoneSuperoxide
The present invention relates to a process for the conversion of phenol to hydroquinone and quinones. More particularly this invention relates to a process for the oxidation of phenol to a mixture of 1,4-benzoquinone and hydroquinone using an oxidant in the presence of titanium superoxide as a reusable catalyst in a liquid phase condition.
Owner:COUNCIL OF SCI & IND RES
Quinone Derivative 2,3-Dimethoxy-5-Methyl-6-(10-Hydroxydecyl)-1,4-Benzoquinone for the Treatment of Muscular Dystrophies
Use of idebenone for the preparation of a medicament for the treating of a muscular dystrophy in particular for treating and / or preventing weakness and / or loss of skeletal muscle tissue and / or cardiomyopathy associated with a muscular dystrophy.
Owner:SANTHERA PHARMA SCHWEIZ
Preparation method of propofol medium/long-chain fat emulsion injection
InactiveCN105616350APrevent oxidationGuaranteed milkHydroxy compound active ingredientsAnaesthetics1,4-BenzoquinoneOil phase
The invention relates to the field of technics and preparation of medicine carrying emulsion, in particular to a preparation method of a propofol medium / long-chain fat emulsion injection. According to the method, 8ppm of 97-percent sodium calcium edentate is added into the prepared water phase; nitrogen gas is inflated for protection in the whole preparation process of a water phase and an oil phase, and the preparation temperature is 55 DEG C; a 121 DEG C and 15min moist heat sterilization method is used for sterilization; and an excessive killing method is used. The preparation method of the propofol medium / long-chain fat emulsion injection has the advantages that the content of main medicine of propofol is protected; the contents of impurities of 2,6-diisopropyl-1,4-benzoquinone and 3,3',5,5'-tetraisopropyl xenol are reduced; the anisidine value content is reduced; and the stability of the medicine carrying emulsion is improved.
Owner:HUAREN PHARMACEUTICAL CO LTD
Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
InactiveUS20100280130A1Treatment safetyRelieve symptomsBiocideNervous disorderProgressive multiple sclerosisMS multiple sclerosis
The present invention relates to approaches, methods, pharmaceuticals and uses directed to the curative treating or preventing of Primary Progressive Multiple Sclerosis (PP-MS), by using 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (Idebenone) as the active agent.
Owner:UNITED STATES OF AMERICA +1
Gluten-free grain-conentrate subsitute for fermented wheat germ food product and method of preparation
ActiveUS20190274319A1Small particle sizeThe process is simple and fastFermented solutions distillation/rectificationPre-baking dough treatmentWheat germ1,4-Benzoquinone
A gluten-free grain concentrate (GFGC) food product and stepwise process to prepare GFGC from the treatment of raw unground wheat germ, is provided resulting in a product having at least three active components including (a) 1% to 3% 2,6-dimethoxy-1,4-hydroquinone; (b) 2% to 4% monomethoxy-1,4-benzoquinone; and (c) 0.5% to 1.5% monomethoxy-1,4-hydroquinone; and at least one inactive component: 2,6 dimethyl benzoquinone.
Owner:WALES DAVID +2
Process for the preparation of substituted trans-cinnamaldehyde, a natural yellow dye, from phenylpropane derivatives
The present invention relates to the preparation of substituted trans-cinnamaldehyde, a natural yellow dye from Phenylpropane derivatives having R2-R3-R4-R5-R6 substitution, wherein R2 to R6 equal or different, being hydrogen or hydroxy or acyl or halogen or alkyl or heterocyclic or aryl or dioxymethylene or alkoxy groups, etc., by oxidizing the said phenylpropane derivatives using a oxidising agent such as 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) or p-chloranil or pyridinium chlorochromate (PCC) or tBuOOH or CrO3 with a catalytic amount of inorganic / organic acid or alumina, celite, and silica gel as a solid support for microwave irradiation and thus substituted trans-cinnamaldehydes, a natural yellow dye, are obtained in high yield ranging from 68-82%.
Owner:COUNCIL OF SCI & IND RES
Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of muscular dystrophies
Owner:SANTHERA PHARMA SCHWEIZ
Method for identifying modulators of CLK-1 and UbiF activity
InactiveUS20040265989A1Increase probabilityLow similarityNervous disorderBacteria1,4-BenzoquinoneMethyl group
The present invention provides methods for screening modulators of 2-polyprenyl-3-methyl-6-methoxy-1,4-benzoquinone (DMQ) hydroxylation activity, inhibitors and activators of the activity, and methods of using such compounds. More particularly, this invention relates to modulators of and UbiF and CLK-1 enzyme activity and methods of identifying same.
Owner:MCGILL UNIV
Preparation method of natural product 2-methyl-3-methoxy-carbazole-1,4-benzoquinone
The invention discloses a preparation method of 2-methyl-3-methoxy-carbazole-1,4-benzoquinone. In the preparation method, 3-bromo-N-Ts indole reacts with 3-methoxy-4-methyl-3-cyclobutene-1,2-diketone to obtain 2-methyl-3-methoxy-carbazole-1,4-benzoquinone, wherein Ts is p-toluenesulfonyl. In the invention, a natural product 2-methyl-3-methoxy-carbazole-1,4-benzoquinone is synthesized by use of commercially available raw materials; the preparation method is simple and realizes convenient separation, high yield and good selectivity.
Owner:NORTHWEST UNIV
A kind of preparation method of permanent violet pigment
The invention discloses a preparation method of a permanent violet pigment. The method comprises the following steps: dissolving 3-amino-N-ethyl carbazole in an organic solvent and carrying out a condensation reaction by adding chloranil in the presence of an acid-binding agent so as to obtain an organic solution containing 2,5-dichloro-3,6-di(9-ethyl-3-carbazole amino)-1,4-benzoquinone after the reaction; adding a metal salt catalyst into the organic solution obtained in the step a or simultaneously adding the metal salt catalyst and a quinone compound cocatalyst into the organic solution; feeding air or oxygen into a reaction kettle to reach a certain pressure; carrying out heat preservation at 120-180 DEG C for 2-10 hours; cooling to 80-120 DEG C after the reaction; washing a filter cake obtained after filtering with a small amount of organic solvent; then, respectively washing with methyl alcohol and water and drying, thereby obtaining a crude permanent violet pigment product. According to the method, a traditional poisonous and harmful closed-loop agent is not adopted, so that the cost of raw materials is saved; the generation of byproducts is reduced, so that the selectivity and total yield of the reaction are improved. Thus, less environmental pollution is generated.
Owner:NANTONG HAIDI CHEM
Synthesis method for triphyrin compound with no center coordination
InactiveCN103923089AHigh synthetic yieldExtended oxidation timeOrganic chemistrySynthesis methods1,4-Benzoquinone
The present invention discloses a synthesis method for a triphyrin compound with no center coordination. According to the present invention, the adopted mixed oxidant is tetrachlorobenzoquinone and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone, and the oxidation time is prolonged so as to significantly improve the synthesis yield of the triphyrin with no center coordination and simplify the process treatment. The synthesis method can be applied for synthesis of the triphyrin compound with no center coordination.
Owner:JIANGSU UNIV
Synthetic method of 1, 2-diol dicarboxylic ester
InactiveCN104693026AOrganic compound preparationCarboxylic acid esters preparationOrganic solvent1,4-Benzoquinone
The invention discloses a synthetic method of 1, 2-diol dicarboxylic ester. The method comprises the following step: by taking 2,3-dichloro-5, 6-dicyan-1,4-benzoquinone as a dehydrogenation agent, carrying out reaction on cycloacetal and carboxylic acid in a dried organic solvent for 6-48 hours at 20-140 DEG C to obtain 1, 2-diol dicarboxylic ester, wherein the molar ratio of cycloacetal to carboxylic acid is (1-10): 1 and the molar ratio of the dehydrogenation agent to carboxylic acid is (1-10): 1. The method overcomes the defects that in the prior art, a strong acid or an expensive coupling agent is required, monoester needs to be pre-prepared when asymmetrical dicarboxylic ester is synthesized, and 1,2-diol in the process is excessive in amount and the like. The synthetic method has the advantages that 1) by taking 2,3-dichloro-5,6-dicyan-1,4-benzoquinone as the dehydrogenation agent, non-metal coupling is realized, and heavy metal ions are prevented from being left in a product; 2) the reaction product is easy to separate and the dehydrogenation agent is easy to regenerate; 3) the process is simple, the cost is low, the product is good in specificity and environmental-friendly; and 4) the conversion efficiency is high. The synthetic method disclosed by the invention plays an important role in industrial production of 1, 2-diol dicarboxylic ester.
Owner:CHANGSHA UNIVERSITY OF SCIENCE AND TECHNOLOGY
Novel red BODIPY fluorescent dye and preparation method and application thereof
InactiveCN102702768BHigh fluorescence quantum efficiencyGood light stabilityMethine/polymethine dyesMicrobiological testing/measurementChemical reaction1,4-Benzoquinone
Owner:TIANJIN UNIVERSITY OF TECHNOLOGY
Method for identifying modulators of CLK-1 and UbiF activity
InactiveUS7132274B2Increase probabilityLow similarityNervous disorderBacteria1,4-BenzoquinoneMethyl group
The present invention provides methods for screening modulators of 2-polyprenyl-3-methyl-6-methoxy-1,4-benzoquinone (DMQ) hydroxylation activity, inhibitors and activators of the activity, and methods of using such compounds. More particularly, this invention relates to modulators of and UbiF and CLK-1 enzyme activity and methods of identifying same.
Owner:MCGILL UNIV
Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of respiratory illness in muscular dystrophy
The present invention relates to 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (idebenone) for treating and / or preventing respiratory illness associated with certain forms of muscular dystrophy.
Owner:SANTHERA PHARMA SCHWEIZ
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com